Reports

Ideas That Generate Results

List of Figures:

Figure 5-1: Global - Orphan Drugs Market (Billion US$), 2014-2020
Figure 6-1: Global - Orphan Drugs Market by Type (%), 2014
Figure 6-2: Global - Orphan Drugs Market by Geography (%), 2014
Figure 6-3: Global - Orphan Drugs Market by Applications (%), 2014
Figure 11-1: Share of Major Players in Orphan Drugs Market (%), 2014
Figure 12-1: Novartis - Breakup of Revenue by Geographies (%), 2014
Figure 12-2: Roche - Breakup of Revenue by Geographies (%), 2014
Figure 12-3: Celgene Corporation - Breakup of Revenue by Geographies (%), 2014
Figure 12-4: Pfizer Inc - Breakup of Revenue by Geographies (%), 2014
Figure 12-5: Sanofi – Breakup of Revenue by Geographies (%), 2014
Figure 12-6: Bristol Myers Squibb – Breakup of Revenue by Geographies (%), 2014
Figure 12-7: Johnson & Johnson - Breakup of Revenue by Geographies (%), 2014
Figure 12-8: Merck & Co., Inc.  - Breakup of Revenue by Geographies (%), 2014
Figure 12-9: Boehringer Ingelheim GmbH - Break up of Revenue by Geographies (%), 2014
Figure 12-10: AbbVie - Break up of Revenue by Geographies (%), 2014

 List of Tables:

Table 7-1: Major Orphan Drugs Pipeline
Table 9-1: Major Consolidations in Orphan Drug Market (2014-2015)
Table 11-1: Global - Major Orphan Drugs Revenue (Billion US$), 2014
Table 12-1: Novartis - Revenue by Business Segments (Billion US$), 2013 & 2014
Table 12-2: Novartis - Orphan Drugs
Table 12-3: Roche - Revenue by Business Segments (Billion US$), 2013 & 2014
Table 12-4: Roche - Orphan Drugs
Table 12-5: Celgene Corporation - Orphan Drugs
Table 12-6: Pfizer Inc - Revenues by Business Segment (Billion US$), 2013 & 2014
Table 12-7: Pfizer Inc - Orphan Drugs
Table 12-8: Sanofi - Revenue by Business Segments (Billion US$), 2013 & 2014
Table 12-9: Sanofi - Orphan Drugs
Table 12-10: Bristol Myers Squibb - Revenue by Business Segments (Billion US$), 2013 & 2014
Table 12-11: Bristol Myers Squibb - Orphan Drugs
Table 12-12: Johnson & Johnson - Revenue by Business Segments (Billion US$), 2013 & 2014
Table 12-13: Johnson & Johnson - Orphan Drugs
Table 12-14: Merck & Co., Inc.  - Revenue by Business Segments (Billion US$), 2013 & 2014
Table 12-15: Merck & Co., Inc.  - Orphan Drugs
Table 12-16: Boehringer Ingelheim GmbH - Revenues by Business Segment (Billion US$), 2013 & 2014
Table 12-17: Boehringer Ingelheim GmbH - Orphan Drugs
Table 12-18: AbbVie - Orphan Drugs